(Q37103576)

18 August 2017

1 reference

title

Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

Shyamal H Mehta

1

1 reference

18 August 2017

John C Morgan

series ordinal

2

1 reference

18 August 2017

Kapil D Sethi

series ordinal

3

1 reference

18 August 2017

publication date

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

13

1 reference

18 August 2017

issue

3 Suppl 4

1 reference

18 August 2017

page(s)

6-11

1 reference

The involvement of dopamine in the modulation of sleep and waking

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

EEG sleep patterns in Parkinsonian patients treated with Bromocryptine and L-Dopa: A comparative study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Parkinson's disease and sleepiness: an integral part of PD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT SPECT in treated patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Antidepressants and their effect on sleep

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's d

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Non-recognition of depression and other non-motor symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Parkinson's disease and sleep

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Sleepiness in Parkinson's disease: a controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Dopaminergic role in stimulant-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

[18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Subjective and objective sleepiness in the active individual.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Hypocretin (orexin) cell loss in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Vigilance states in a parkinsonian model, the MPTP mouse

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Suppression of REM rebound by Pergolide

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

FAST TRACK: daytime sleepiness in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Sleep and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Respiration and sleep in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Daytime sleepiness and alertness in patients with Parkinson disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Assessment of sleep and sleepiness in Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Quantification of Sleepiness: A New Approach

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Deep brain stimulation and its effect on sleep in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Sleep breathing disorders in patients with idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

Dopamine receptors: from structure to behavior

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017260

7 January 2021

10.1017/S1092852900017260

Identifiers

DOI

0 references

1 reference